# COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria

> **NCT00123903** · PHASE3 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 1220 (—)

## Conditions studied

- Heart Failure, Congestive and Microalbuminuria

## Interventions

- **DRUG:** metoprolol xl
- **DRUG:** carvedilol MR
- **DRUG:** lisinopril

## Key facts

- **NCT ID:** NCT00123903
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 1220 (—)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00123903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00123903, "COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00123903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*